Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer [Phase 3]
A Phase 3 trial is evaluating neoadjuvant CAPOX plus tislelizumab vs CAPOX alone in MSS high-risk locally advanced colon cancer. The study s…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Multi-Reader Multi-Case Trial Evaluating Computer-Aided Tool for Prognostic Prediction of Colorectal Liver Metastases
Clinical trial update for a multi-reader, multi-case study evaluating a computer-aided prognostic tool for colorectal liver metastases, curr…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC [NA]
This clinical trial update notes the completion of a study evaluating targeted evidence-based interventions to increase colorectal cancer sc…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy [Phase 2]
A Phase 2 clinical trial update examining the optimal dose intensity of LONSURF with G-CSF in metastatic colorectal cancer; the study is cur…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Mayo Clinic is recruiting a study that collects blood and stool samples from Lynch syndrome patients to detect colorectal cancer or advanced…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-08-17Clinical Trial Update: Reduction of Conscious Sedation Requirements by Olfactory Stimulation [NA]
A clinical trial evaluating whether olfactory stimulation reduces conscious sedation requirements has been withdrawn.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver [Phase 2]
Phase 2 clinical trial update evaluating hepatic arterial infusion with floxuridine and dexamethasone in combination chemotherapy for colore…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Effect of a Resilience Model-Based Program for Patients With Newly Diagnosed Colorectal Cancer [NA]
A completed clinical trial evaluating a resilience model-based program for patients with newly diagnosed colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Nurse-assisted Intervention "eHealth@ Hospital -2-home" [NA]
This clinical trial update indicates the nurse-assisted intervention 'eHealth@ Hospital-2-home' is sponsored by the University of Stavanger …
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. [Phase 2]
A Phase 2 clinical trial evaluating SPH5030 tablets for HER2-positive/mutated biliary tract cancer or colorectal cancer is currently recruit…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit [NA]
This document presents the clinical performance study protocol for the Therascreen KRAS RGQ PCR Kit, a diagnostic test used in metastatic co…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: 5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab [Phase 2]
Phase 2 trial evaluating first-line treatment for unresectable colorectal cancer with KRAS G12C mutation using a combination of 5-fluorourac…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in adults with advanced solid tumors, cur…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study Comparing Standard and AI-Assisted Colonoscopies for Detecting and Characterizing Colorectal Lesions in Adults Aged 50-74 Undergoing Cancer Screening [NA]
A completed clinical trial comparing standard versus AI-assisted colonoscopy for detecting and characterizing colorectal lesions in adults 5…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients [NA]
This clinical trial update shows that a study testing minimal residual disease for early detection of recurrence in patients with resectable…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial [NA]
This ClinicalTrials.gov update describes the COURAGE trial, evaluating whether exercise can influence the gut microbiome in young-onset colo…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer [NA]
Clinical trial registry entry for a national cohort study evaluating prognostic factors for the efficacy of Fruquintinib in patients with me…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer [Phase 3]
Pfizer is conducting a Phase 3 study of encorafenib (Braftovi) plus cetuximab, with or without chemotherapy, in previously untreated metasta…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors [Phase 1]
A Phase 1 trial evaluating tovorafenib (DAY101) alone or with pimasertib for melanoma and other solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer [Phase 2]
Phase 2 trial evaluating liposomal irinotecan (Onivyde) in combination with 5-FU/leucovorin and bevacizumab for advanced colorectal cancer. …
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery
This clinical trial is evaluating the Enhanced Recovery After Surgery (ERAS) system in colorectal surgery. The study includes patients with …
-
CLINICAL_TRIALS other · 2025-08-13Clinical Trial Update: A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial comparing the nivolumab-relatlimab fixed-dose combination versus regorafenib or TAS-102 in patients with later-line metastatic…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal Cancer [Phase 1, Phase 2]
An ongoing Phase 1/2 trial evaluating TQB2922 plus TAS-102 (trifluridine/tipiracil) with or without bevacizumab in patients with chemotherap…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers [Phase 1]
Phase 1 clinical trial examining the biodistribution of the Ga-68 labeled imaging tracer 68Ga-FAPi-46 in patients with solid tumors and hema…